Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
da Penha Gomes Gouvea M, Lira Machado KLL, de Oliveira YGP, Moulaz IR, Henriques AG, Gouveia TM, Thompson BP, Lança KEM, de Souza Ramos S, Lacerda GCC, Lenzi JPG, de Castro Pimentel F, Miossi JPM, Rassele ML, Camacho LAB, Villela DAM, de Lima SMB, de Souza Azevedo A, Horbach IS, de Araújo MF, Tort LFL, de Oliveira ACA, Siqueira MM, Garcia CC, da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, da Silva VG, Miyamoto ST, Dos Santos Fantoni RN, Pinto-Neto LF, Magda Domingues C, de Medeiros Junior NF, Burian AP, Teixeira-Carvalho A, Mota LMH, Mill JG, Martins-Filho OA, Valim V. da Penha Gomes Gouvea M, et al. Among authors: valim v. Vaccine. 2023 Oct 20;41(44):6514-6528. doi: 10.1016/j.vaccine.2023.08.022. Epub 2023 Sep 1. Vaccine. 2023. PMID: 37661534
Unbalanced networks and disturbed kinetics of serum soluble mediators associated with distinct disease outcomes in severe COVID-19 patients.
Jardim-Santos GP, Schulte HL, Kurizky PS, Gomes CM, Nóbrega OT, de Gois ET, de Carvalho MRM, Martins FP, Nicola AM, de Albuquerque CP, Espindola LS, Naves LA, Soares AASM, Albuquerque P, Fontes W, do Amaral LR, Gomes MS, Bertarini PLL, Brito-de-Sousa JP, Campi-Azevedo AC, Peruhype-Magalhães V, Teixeira-Carvalho A, Valim V, Martins-Filho OA, da Mota LMH. Jardim-Santos GP, et al. Among authors: valim v. Front Immunol. 2022 Nov 14;13:1004023. doi: 10.3389/fimmu.2022.1004023. eCollection 2022. Front Immunol. 2022. PMID: 36451835 Free PMC article.
Serum soluble mediators as prognostic biomarkers for morbidity, disease outcome, and late-relapsing hepatitis in yellow fever patients.
Fradico JRB, Campi-Azevedo AC, Speziali E, do Valle Antonelli LR, Peruhype-Magalhães V, de Rezende IM, Alves PA, Pascoal-Xavier MA, Pereira LS, Dutra MRT, Ramalho DB, Cenachi A, de Paula L, Santos TA, do Carmo Said RF, Calzavara-Silva CE, Coelho-Dos-Reis JGA, de Magalhães CR, Rabelo LLC, Valim V, Brito-de-Sousa JP, da Costa-Rocha IA, de Souza Gomes M, Amaral LR, de Lima SMB, Trindade GF, Santos RT, da Silva JFA, Monath T, LaBeaud AD, Drumond BP, Martins-Filho OA, Teixeira-Carvalho A; Yellow Fever Collaborative Group. Fradico JRB, et al. Among authors: valim v. Clin Immunol. 2023 Jun;251:109321. doi: 10.1016/j.clim.2023.109321. Epub 2023 Apr 3. Clin Immunol. 2023. PMID: 37019421
Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study.
Fernandes GM, Sasaki LMP, Jardim-Santos GP, Schulte HL, Motta F, da Silva ÂP, de Carvalho AO, Pereira YR, Alves CO, de Araújo Júnior DA, Mendonça-Silva DL, Costa KN, de Castro MEC, Lauand L, Nery RR, Tristão R, Kurizky PS, Nóbrega OT, Espindola LS, de Castro LCG, Alpoim PN, Godoi LC, Dusse LMSA, Coelho-Dos-Reis JGA, do Amaral LR, Gomes MS, Bertarini PLL, Brito-de-Sousa JP, da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, Teixeira-Carvalho A, Zaconeta AM, Soares AASM, Valim V, Gomes CM, de Albuquerque CP, Martins-Filho OA, da Mota LMH. Fernandes GM, et al. Among authors: valim v. Front Immunol. 2023 Apr 12;14:1176898. doi: 10.3389/fimmu.2023.1176898. eCollection 2023. Front Immunol. 2023. PMID: 37122732 Free PMC article.
Half dose ChAdOx1 nCoV-19 vaccine was equivalent to full doses to reduce moderate and severe COVID-19 cases.
Galvão-Lima LJ, de Medeiros Júnior NF, Jesus GS, Morais AHF, Caldeira-Silva GJP, Queiroz Dos Santos JP, Rocha M, Marques Dos Santos M, Freire PA, Silva RD, Gouvea MDPG, Neto LFP, Domingues CMAS, Teixeira-Carvalho A, Martins-Filho OA, Valim V, Valentim RAM. Galvão-Lima LJ, et al. Among authors: valim v. IJID Reg. 2023 Sep 30;9:88-94. doi: 10.1016/j.ijregi.2023.09.007. eCollection 2023 Dec. IJID Reg. 2023. PMID: 37953882 Free PMC article.
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
Horbach IS, de Souza Azevedo A, Schwarcz WD, Alves NDS, de Moura Dias B, Setatino BP, da Cruz Moura L, de Souza AF, Denani CB, da Silva SA, Pimentel TG, de Oliveira Silva Ferreira V, Azamor T, Ano Bom APD, da Penha Gomes Gouvea M, Mill JG, Valim V, Polese J, Campi-Azevedo AC, Peruhype-Magalhães V, Teixeira-Carvalho A, Martins-Filho OA, de Lima SMB, de Sousa Junior IP. Horbach IS, et al. Among authors: valim v. Diseases. 2024 Jan 18;12(1):29. doi: 10.3390/diseases12010029. Diseases. 2024. PMID: 38248380 Free PMC article.
Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.
Calderaro DC, Valim V, Ferreira GA, Machado KLLL, Ribeiro PDC, Ribeiro SLE, Sartori NS, de Rezende RPV, de Melo AKG, Cruz VA, Vieira ASR, Kakehasi AM, de Landa AT, Burian APN, Peixoto FMMMC, Telles CMPF, do Espírito Santo RC, Baptista KL, de Oliveira YGP, Magalhães VO, de Lima RL, Biegelmeyer E, Lorencini PZ, Teixeira-Carvalho A, Dos Reis-Neto ET, Sato EI, Pinheiro MM, Monticielo OA, de Souza VA, Xavier RM, Pileggi GS; SAFER-Study Group Task Force. Calderaro DC, et al. Among authors: valim v. Vaccines (Basel). 2024 Sep 9;12(9):1031. doi: 10.3390/vaccines12091031. Vaccines (Basel). 2024. PMID: 39340061 Free PMC article.
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Machado KLLL, Burian APN, Martins-Filho OA, Mill JG, Ferreira LB, Tapia KRL, Moulin ACS, Moulaz IR, Ribeiro PDC, Magalhães VO, Biegelmeyer E, Peixoto FMMMC, Ribeiro SLE, Telles CMPF, Bühring J, Sartorio NS, Hax V, Rezende RPV, Baptista KL, Melo AKG, Cruz VA, Vieira RMRA, Azevedo RH, Azevedo VF, Pinheiro MM, Monticielo OA, Reis Neto ETD, Teixeira-Carvalho A, Xavier RM, Sato EI, de Souza VA, Ferreira GA, Pileggi GS, Valim V. Machado KLLL, et al. Among authors: valim v. Vaccines (Basel). 2024 Dec 3;12(12):1367. doi: 10.3390/vaccines12121367. Vaccines (Basel). 2024. PMID: 39772029 Free PMC article.
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients.
Brito-Zerón P, Melchor S, Seror R, Priori R, Solans R, Kostov B, Baldini C, Carubbi F, Callejas JL, Guisado-Vasco P, Hernández-Molina G, Pasoto SG, Valim V, Sisó-Almirall A, Mariette X, Carreira P, Ramos-Casals M; Sjögren Big Data Consortium, Members of the EULAR-SS Task Force Big Data Consortium who contributed to this study. Brito-Zerón P, et al. Among authors: valim v. Rheumatology (Oxford). 2021 Jun 18;60(6):2946-2957. doi: 10.1093/rheumatology/keaa748. Rheumatology (Oxford). 2021. PMID: 33316070 Free PMC article.
Brazilian version of the "Primary Sjögren's Syndrome - Quality of Life questionnaire (PSS-QoL)": translation, cross-cultural adaptation and validation.
Miyamoto ST, Serrano ÉV, Gianórdoli APE, Altoé LB, Noronha BD, Dos Santos PHA, Pedrini APT, da Silva NRS, Favarato LF, Alochio LV, Tomé WA, Lackner A, Valim V. Miyamoto ST, et al. Among authors: valim v. Adv Rheumatol. 2024 Aug 19;64(1):60. doi: 10.1186/s42358-024-00395-7. Adv Rheumatol. 2024. PMID: 39160602
117 results